Dr. Kevin M Kalinsky, MD
Claim this profileEmory University Hospital/Winship Cancer Institute
Expert in Breast Cancer
Studies Breast cancer
13 reported clinical trials
30 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage IV
ER positive
HER2 positive
2Breast Cancer
HER2 positive
ER positive
Stage IV
Affiliated Hospitals
Clinical Trials Kevin M Kalinsky, MD is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Neratinib
for Breast Cancer
This phase II trial tests how well neratinib prior to the primary treatment (neoadjuvant) works in treating patients with stage I-III HER2 mutated lobular breast cancers. Neratinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells. Giving neratinib in addition to normal therapy may work better in treating cancer than the endocrine therapy patients would normally receive.
Recruiting1 award Phase 2
More about Kevin M Kalinsky, MD
Clinical Trial Related2 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Kevin M Kalinsky, MD has experience with
- Gemcitabine
- ProAgio
- ARX788
- INX-315
- Paclitaxel
- Trastuzumab
Breakdown of trials Kevin M Kalinsky, MD has run
Breast Cancer
Breast cancer
Pancreatic Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kevin M Kalinsky, MD specialize in?
Kevin M Kalinsky, MD focuses on Breast Cancer and Breast cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are ER positive.
Is Kevin M Kalinsky, MD currently recruiting for clinical trials?
Yes, Kevin M Kalinsky, MD is currently recruiting for 7 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Kevin M Kalinsky, MD has studied deeply?
Yes, Kevin M Kalinsky, MD has studied treatments such as Gemcitabine, ProAgio, ARX788.
What is the best way to schedule an appointment with Kevin M Kalinsky, MD?
Apply for one of the trials that Kevin M Kalinsky, MD is conducting.
What is the office address of Kevin M Kalinsky, MD?
The office of Kevin M Kalinsky, MD is located at: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University Hospital/Winship Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.